Ankur Jindal

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Prognostic Factors

Pulmonary Hypertension

Ejection Fraction

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology communications

Digestive diseases and sciences

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Amar Mukund, Ashish Aravind, Ankur Jindal, Harsh Vardhan Tevethia, Yashwant Patidar, Shiv K Sarin
Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis. Digestive diseases and sciences 69 (3) (2024)
Amar Mukund, Ashish Aravind, Ankur Jindal, Harsh Vardhan Tevethia, Yashwant Patidar, Shiv K Sarin
Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis. Digestive diseases and sciences 69 (3) (2024)
Chitranshu Vashishtha, Ankit Bhardwaj, Ankur Jindal, Manoj Kumar Sharma, Shiv Kumar Sarin
Effect of midodrine on HVPG in advanced chronic liver disease and acute-on-chronic liver failure-A pilot study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Amar Mukund, Ashish Aravind, Ankur Jindal, Harsh Vardhan Tevethia, Yashwant Patidar, Shiv K Sarin
Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis. Digestive diseases and sciences (2024)
Vikash Prakash, Vinod Arora, Ankur Jindal, Rakhi Maiwall, Shiv Kumar Sarin
Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult to treat SBP:A randomized controlled trial. Liver international : official journal of the International Association for the Study of the Liver (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Amar Mukund, Uday Kumar Marri, Ankur Jindal, Ashok Choudhury, Yashwant Patidar, Shiv Kumar Sarin
Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy. Digestive diseases and sciences (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Mojahidul Islam, Karan Kumar, Jayesh Kumar Sevak, Ankur Jindal, Ashish Kumar Vyas, Gayatri Ramakrishna, Shyamasundaran Kottilil, Manoj Kumar Sharma, Shiv Kumar Sarin, Nirupama Trehanpati
Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology communications 7 (5) (2023)
Vikash Prakash, Vinod Arora, Ankur Jindal, Rakhi Maiwall, Shiv Kumar Sarin
Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult-to-treat spontaneous bacterial peritonitis: A randomized controlled trial. Liver international : official journal of the International Association for the Study of the Liver (2023)
Puja Sahai, Ankur Jindal, Amar Mukund
Letter to the editor: Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant. Hepatology (Baltimore, Md.) 75 (5) (2022)
Ankur Jindal, Shiv Kumar Sarin
Epidemiology of liver failure in Asia-Pacific region. Liver international : official journal of the International Association for the Study of the Liver 42 (9) (2022)
Ankur Jindal, Shiv K Sarin
Hepatitis B: "Treat all" or "Treat select". Hepatology international (2022)
Ashish Kumar Vyas, Ankur Jindal
Letter: sPD-1 as a predictor for HBsAg seroconversion-shed light on inactive carriers with chronic hepatsitis B. Alimentary pharmacology & therapeutics 55 (8) (2022)
Mojahidul Islam, Jayesh Kumar Sevak, Manoj Kumar Sharma, Ankur Jindal, Ashish Kumar Vyas, Meenu Bajpai, Gayatri Ramakrishna, Shiv Kumar Sarin, Nirupama Trehanpati
Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. Alimentary pharmacology & therapeutics (2022)
Ankur Jindal, Amar Mukund, Chaggan Bihari
Primary yolk sac tumour of liver. Liver international : official journal of the International Association for the Study of the Liver 41 (9) (2021)
Amrish Sahney, Barjesh Chander Sharma, Ankur Jindal, Lovkesh Anand, Vinod Arora, Rajan Vijayaraghavan, Ravinder Mohan Dhamija, Guresh Kumar, Ankit Bhardwaj, Shiv Kumar Sarin
A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism. Liver international : official journal of the International Association for the Study of the Liver 39 (4) (2019)
Ashish K Vyas, Ankur Jindal
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus. Alimentary pharmacology & therapeutics 49 (6) (2019)
Ankur Jindal, Amar Mukund, Guresh Kumar, Shiv Kumar Sarin
Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis. Liver international : official journal of the International Association for the Study of the Liver 39 (11) (2019)
Ajeet Singh Bhadoria, Chandan Kumar Kedarisetty, Chhagan Bihari, Guresh Kumar, Ankur Jindal, Ankit Bhardwaj, Varsha Shasthry, Jaya Benjamin, Manoj Kumar Sharma, Shiv Kumar Sarin
Positive familial history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross-sectional study. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)